Oregon’s colonoscopy trailblazer steps into new leadership role

Colorectal screening, primarily by colonoscopy, contributed to a steep drop in cancer incidence (Yang et al. 2014). David Lieberman, M.D., professor and head of gastroenterology and hepatology in...

Making sense of colorectal cancer screening choices

Colorectal cancer is the third most common cause of cancer death among men and women in the U.S. But there is shockingly large regional variation in mortality, in part because of sharp differences...

New insight into the anti-cancer effect of aspirin

For reasons that remain uncertain, people who take aspirin on a regular basis have a reduced risk of colorectal cancer and certain other malignancies. Now researchers have identified a...

Predicting colon polyp risk from microRNA

Differences in microRNA in colon polyps may help identify high risk cases that require more frequent follow-up screening, according to a study with four OHSU co-authors that is featured on the cover...

Making better decisions to prevent colon cancer

Colorectal cancer mortality rates (per 100,000) are as much as six times higher in red counties than in those colored dark blue. (Source: NCI SEER data 2007-2011) To prevent deaths from colon...

Wanted: Patients’ perspectives on cancer research

Five years ago, Betty Booher’s husband was diagnosed with primary cancers in the colon and the pancreas and died at age 57. In the aftermath, she says, “It was important to me to find a way to...